JPS56161893U - - Google Patents
Info
- Publication number
- JPS56161893U JPS56161893U JP5986480U JP5986480U JPS56161893U JP S56161893 U JPS56161893 U JP S56161893U JP 5986480 U JP5986480 U JP 5986480U JP 5986480 U JP5986480 U JP 5986480U JP S56161893 U JPS56161893 U JP S56161893U
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5986480U JPS56161893U (de) | 1980-05-02 | 1980-05-02 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5986480U JPS56161893U (de) | 1980-05-02 | 1980-05-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS56161893U true JPS56161893U (de) | 1981-12-02 |
Family
ID=29654332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5986480U Pending JPS56161893U (de) | 1980-05-02 | 1980-05-02 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS56161893U (de) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8962700B2 (en) | 2006-10-25 | 2015-02-24 | Revalesio Corporation | Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures |
US8980325B2 (en) | 2008-05-01 | 2015-03-17 | Revalesio Corporation | Compositions and methods for treating digestive disorders |
US9011922B2 (en) | 2009-04-27 | 2015-04-21 | Revalesio Corporation | Compositions and methods for treating insulin resistance and diabetes mellitus |
US9034195B2 (en) | 1997-10-24 | 2015-05-19 | Revalesio Corporation | Diffuser/emulsifier for aquaculture applications |
US9198929B2 (en) | 2010-05-07 | 2015-12-01 | Revalesio Corporation | Compositions and methods for enhancing physiological performance and recovery time |
US9402803B2 (en) | 2006-10-25 | 2016-08-02 | Revalesio Corporation | Methods of wound care and treatment |
US9492404B2 (en) | 2010-08-12 | 2016-11-15 | Revalesio Corporation | Compositions and methods for treatment of taupathy |
US9512398B2 (en) | 2006-10-25 | 2016-12-06 | Revalesio Corporation | Ionic aqueous solutions comprising charge-stabilized oxygen-containing nanobubbles |
US9523090B2 (en) | 2007-10-25 | 2016-12-20 | Revalesio Corporation | Compositions and methods for treating inflammation |
-
1980
- 1980-05-02 JP JP5986480U patent/JPS56161893U/ja active Pending
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9034195B2 (en) | 1997-10-24 | 2015-05-19 | Revalesio Corporation | Diffuser/emulsifier for aquaculture applications |
US8962700B2 (en) | 2006-10-25 | 2015-02-24 | Revalesio Corporation | Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures |
US9004743B2 (en) | 2006-10-25 | 2015-04-14 | Revalesio Corporation | Mixing device for creating an output mixture by mixing a first material and a second material |
US9402803B2 (en) | 2006-10-25 | 2016-08-02 | Revalesio Corporation | Methods of wound care and treatment |
US9512398B2 (en) | 2006-10-25 | 2016-12-06 | Revalesio Corporation | Ionic aqueous solutions comprising charge-stabilized oxygen-containing nanobubbles |
US9511333B2 (en) | 2006-10-25 | 2016-12-06 | Revalesio Corporation | Ionic aqueous solutions comprising charge-stabilized oxygen-containing nanobubbles |
US9523090B2 (en) | 2007-10-25 | 2016-12-20 | Revalesio Corporation | Compositions and methods for treating inflammation |
US8980325B2 (en) | 2008-05-01 | 2015-03-17 | Revalesio Corporation | Compositions and methods for treating digestive disorders |
US9011922B2 (en) | 2009-04-27 | 2015-04-21 | Revalesio Corporation | Compositions and methods for treating insulin resistance and diabetes mellitus |
US9272000B2 (en) | 2009-04-27 | 2016-03-01 | Revalesio Corporation | Compositions and methods for treating insulin resistance and diabetes mellitus |
US9198929B2 (en) | 2010-05-07 | 2015-12-01 | Revalesio Corporation | Compositions and methods for enhancing physiological performance and recovery time |
US9492404B2 (en) | 2010-08-12 | 2016-11-15 | Revalesio Corporation | Compositions and methods for treatment of taupathy |